Coya Therapeutics, Inc.

COYA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$15-$8-$12-$5
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$3$1$0$0
Change in WC$2-$5$1$1
Other Non-Cash$0$1$4-$0
Operating Cash Flow-$10-$11-$7-$4
Investing Activities
PP&E Inv.$0$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0-$1-$1$0
Investing Cash Flow-$0-$1-$1-$0
Financing Activities
Debt Repay.$0$0$10$0
Stock Issued$14$38$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$2$0-$1-$0
Financing Cash Flow$16$38$9-$0
Forex Effect$0$0$0$0
Net Chg. in Cash$6$27$2-$4
Supplemental Information
Beg. Cash$33$6$4$9
End Cash$38$33$6$4
Free Cash Flow-$10-$11-$7-$4
Coya Therapeutics, Inc. (COYA) Financial Statements & Key Stats | AlphaPilot